Michiel Tent summarises 6 abstracts from the EAN Congress 2021:
- Cognitive and behavioral features of a cohort of patients in COVID-19 post-acute phase.
Agosta F, et al. EAN virtual meeting, 19-22 June 2021, EPR-067. - Dexamethasone versus Surgical Treatment for Chronic Subdural Hematoma: The DECSA trial.
Miah IP, et al. EAN 2021 Virtual Congress, 19-22 June, OS4003. - Erenumab versus topiramate for the prevention of migraine: Results of a randomised, active-controlled, double-dummy trial (HER-MES).
Reuter U, et al. EAN 2021 Virtual Congress, 19-22 June, OS4003. - Observational study on real-life experience with alemtuzumab in naïve patients with aggressive MS.
Moiola L, et al. EAN 2021 Virtual Congress, 19-22 June, OPR-191. - COVID-19 in patients with dementia: clinical features and predictive factors of mortality in a cohort of 125 patients.
Vrillon A, et al. EAN 2021 Virtual Congress, 19-22 June, OPR-144. - The Mozart effect. Why is Mozart better than Haydn?
Rektor I, et al. EAN virtual meeting, 19-22 June 2021, EPR-145.
- Cognitive and behavioral features of a cohort of patients in COVID-19 post-acute phase.
Posted on
Table of Contents: EAN 2021
Featured articles
Letter from the Editor
COVID-19
First evidence of brainstem involvement in COVID-19
Cognitive/behavioural alterations persistent after COVID-19
Neural base of persistent hyposmia after COVID-19
Neurological symptoms and complications of COVID-19 affect outcomes
Cerebrovascular Disease
Intracerebral haemorrhage only slightly increases mortality in COVID-19 patients
Stroke with covert brain infarction indicates high vascular risk
Expanding precision medicine to stroke care
Dexamethasone not indicated for chronic subdural haematoma
Cognitive Impairment and Dementia
Severe outcomes of COVID-19 in patients with dementia
Promising diagnostic accuracy of plasma GFAP
Sex modulates effect of cognitive reserve on subjective cognitive decline
Hypersensitivity to uncertainty in subjective cognitive decline
Epilepsy
Minimally invasive device to detect focal seizure activity
‘Mozart effect’ in epilepsy: why Mozart tops Haydn
Migraine and Headache
Factors associated with decreased migraine attack risk
Pregnant migraine patients at higher risk of complications
Occipital nerve stimulation in drug-resistant cluster headache
Rhythmicity in primary headache disorders
Multiple Sclerosis and NMOSD
Typing behaviour to remotely monitor clinical MS status
Alemtuzumab in treatment-naïve patients with aggressive MS
No higher early MS relapse frequency after stopping ponesimod
Good long-term safety and efficacy of inebilizumab in NMOSD
Neuromuscular Disorders
Inability to recognise disgust as first cognitive symptom of ALS
Pathogenic T-cell signature identified in myasthenia gravis
Parkinson’s Disease
Levodopa-carbidopa intestinal gel in patients with advanced PD
New Frontier – Navigated Transcranial Ultrasound
Exploring the possibilities
site created by:
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com